Matches in Nanopublications for { ?s ?p "[The risk of developing colorectal or endometrial cancer was higher in MSH2 mutation carriers than in MLH1 mutation carriers, but the difference was not significant (P = .13 and P = .057, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP365935.RAm2Dfi1oy3XLS2eCr6dLhoUdVsMp4O5WmBwa3rU-AjoQ130_assertion description "[The risk of developing colorectal or endometrial cancer was higher in MSH2 mutation carriers than in MLH1 mutation carriers, but the difference was not significant (P = .13 and P = .057, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP365935.RAm2Dfi1oy3XLS2eCr6dLhoUdVsMp4O5WmBwa3rU-AjoQ130_provenance.
- NP170767.RAgkN_AK8hmejfBbMmBbYH-y1TlhaGb5JxslVkrVimtBc130_assertion description "[The risk of developing colorectal or endometrial cancer was higher in MSH2 mutation carriers than in MLH1 mutation carriers, but the difference was not significant (P = .13 and P = .057, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP170767.RAgkN_AK8hmejfBbMmBbYH-y1TlhaGb5JxslVkrVimtBc130_provenance.
- assertion description "[The risk of developing colorectal or endometrial cancer was higher in MSH2 mutation carriers than in MLH1 mutation carriers, but the difference was not significant (P = .13 and P = .057, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The risk of developing colorectal or endometrial cancer was higher in MSH2 mutation carriers than in MLH1 mutation carriers, but the difference was not significant (P = .13 and P = .057, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP333205.RAVo_YgqPmVsq5dT7dcszgZqKTI7qX20K2pAgMLtrR1qk130_assertion description "[The risk of developing colorectal or endometrial cancer was higher in MSH2 mutation carriers than in MLH1 mutation carriers, but the difference was not significant (P = .13 and P = .057, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP333205.RAVo_YgqPmVsq5dT7dcszgZqKTI7qX20K2pAgMLtrR1qk130_provenance.
- NP333207.RAYxrZzPQ0mY0UxwvW5N9SLjQHvyo72IIpWfTp5TzRoEc130_assertion description "[The risk of developing colorectal or endometrial cancer was higher in MSH2 mutation carriers than in MLH1 mutation carriers, but the difference was not significant (P = .13 and P = .057, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP333207.RAYxrZzPQ0mY0UxwvW5N9SLjQHvyo72IIpWfTp5TzRoEc130_provenance.
- assertion description "[The risk of developing colorectal or endometrial cancer was higher in MSH2 mutation carriers than in MLH1 mutation carriers, but the difference was not significant (P = .13 and P = .057, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP333209.RAtcERJF3JEXBBbEH77wt7GtB5Vhxxc7M0vWkR65vHjrE130_assertion description "[The risk of developing colorectal or endometrial cancer was higher in MSH2 mutation carriers than in MLH1 mutation carriers, but the difference was not significant (P = .13 and P = .057, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP333209.RAtcERJF3JEXBBbEH77wt7GtB5Vhxxc7M0vWkR65vHjrE130_provenance.